1) Bornkamp B, Bretz F, Dmitrienko A, Enas G, Gaydos B, Hsu CH, et al. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat 2007; 17(6): 965-95.
2) Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA; ASTIN Study Investigators. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN) : an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003; 34: 2543-8.